Christopher Anzalone is listed as an executive officer and director on 7 SEC Form D filings by 2 issuers between Aug 2009 and Oct 2013: ARROWHEAD RESEARCH CORP (Pasadena, CA — biotechnology — 2009–2013; $64M reported sold to 27 investors) and Leonardo Biosystems, Inc. (Houston, TX — other technology — 2010; $1.25M reported sold to 1 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 4 years. Across those companies the filings report $65.3M sold in total.
Listed alongside Charles McKenney (6 shared filings), Edward Frykman (6 shared filings), Mauro Ferrari (4 shared filings), Robert Bruce Stewart (4 shared filings), Bruce Given (3 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Christopher. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 5 court cases matching the name, 2 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 7 public filings for Christopher Anzalone and found 10 differences, 2 worth asking the sponsor about: 5 court cases name Christopher Anzalone; 91% of the money raised went to insiders; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.